Detalles de la búsqueda
1.
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.
Cancer
; 122(15): 2418-25, 2016 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27176138
2.
APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy.
Future Oncol
; 12(12): 1469-81, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26997579
3.
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.
Lancet Oncol
; 16(9): 1071-1078, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26272768
4.
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.
Lancet Oncol
; 16(9): 1079-1089, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26272769
5.
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 28(11): 2237-2247, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35363301
6.
Optimal timing of chemotherapy in androgen independent prostate cancer.
Urol Oncol
; 27(1): 97-100, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19111808
7.
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial.
Cancer Manag Res
; 9: 179-187, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28579832
8.
Dosing patterns, toxicity, and outcomes in patients treated with first-line sunitinib for advanced renal cell carcinoma in community-based practices.
Clin Genitourin Cancer
; 12(6): 413-21, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25163396
9.
Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.
Cancer
; 113(8): 2205-14, 2008 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18780322
10.
Gastrointestinal stromal tumors: imatinib and beyond.
Curr Treat Options Oncol
; 7(6): 427-37, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17032555
Resultados
1 -
10
de 10
1
Próxima >
>>